690
Views
6
CrossRef citations to date
0
Altmetric
Original Articles

Effects of Achillea millefolium on cisplatin induced ocular toxicity: an experimental study

, , , , , & show all
Pages 214-220 | Received 26 Jan 2021, Accepted 10 Apr 2021, Published online: 28 Jun 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Irmak Ferah Okkay, Ufuk Okkay, Cemil Bayram, Betul Cicek, Selma Sezen, Ismail Cagri Aydin, Ali Sefa Mendil & Ahmet Hacimuftuoglu. (2023) Bromelain protects against cisplatin-induced ocular toxicity through mitigating oxidative stress and inflammation. Drug and Chemical Toxicology 46:1, pages 69-76.
Read now

Articles from other publishers (5)

Noor Majid Raheem & Naza Mohammed Ali Mahmood. (2023) Azilsartan suppresses the antiapoptotic biomarker and pro-inflammatory cytokines in rat model of cisplatin-induced retinal and optic nerve toxicity. Human & Experimental Toxicology 42, pages 096032712311550.
Crossref
Ritika, Rizwana, Abhishek Dutt Tripathi & Aparna Agarwal. 2023. Immunity Boosting Medicinal Plants of the Western Himalayas. Immunity Boosting Medicinal Plants of the Western Himalayas 29 57 .
Gökçe Bağcı Uzun, Mehtap Nisari, Arzu Hanım Yay, Gökçe Şeker Karatoprak, Özge Al, Sümeyye Uçar & Ayla Arslan. (2022) Investigating the anti-tumoral effect of yarrow (Achillea milllefolium) on the mice in which ehrlich solid tumor is created. Medical Oncology 40:1.
Crossref
Ufuk OKKAY & Irmak FERAH OKKAY. (2022) Beneficial effects of linagliptin in cell culture model of Parkinson’s disease. The European Research Journal.
Crossref
Irmak Ferah Okkay, Ufuk Okkay, Betul Cicek, Aysegul Yilmaz, Fatma Yesilyurt, Ali Sefa Mendil & Ahmet Hacimuftuoglu. (2021) Neuroprotective effect of bromelain in 6-hydroxydopamine induced in vitro model of Parkinson’s disease. Molecular Biology Reports 48:12, pages 7711-7717.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.